Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
---|
06/25/2013 | US8470585 Process for adenovirus purification from high cell density cultures |
06/25/2013 | US8470580 Method for the selection of recombination clones comprising a sequence encoding an antidote protein to a toxic molecule |
06/25/2013 | US8470578 Purification of vaccinia viruses using hydrophobic interaction chromatography |
06/25/2013 | US8470577 Viral vectors and their use in therapeutic methods |
06/25/2013 | US8470576 Group of novel enantioselective microbial nitrile hydratases with broad substrate specificity |
06/25/2013 | US8470572 Ketoreductase polypeptides for the production of azetidinone |
06/25/2013 | US8470571 Delta-8 desaturase and its use in making polyunsaturated fatty acids |
06/25/2013 | US8470568 Methods and compositions for producing squalene using yeast |
06/25/2013 | US8470559 Growth hormone fusion proteins |
06/25/2013 | US8470557 Isolated nucleic acids encoding activated factor V and methods for production thereof |
06/25/2013 | US8470556 Nucleic acids that encode antigen binding proteins that bind PAR-2 |
06/25/2013 | US8470555 Protein substance having triple helix structure and manufacturing method therefor |
06/25/2013 | US8470554 Prokaryotic expression of soluble, active Dkk |
06/25/2013 | US8470552 Strategy to reduce lactic acid production and control PH in animal cell culture |
06/25/2013 | US8470551 Surface expression vector for fusion protein of Myo-2 peptide multimer and myostatin, and microorganism transformed by thereof |
06/25/2013 | US8470545 Methods of modulating cold sensory perception via a cold- and menthol-sensitive receptor (CMR1) |
06/25/2013 | US8470522 Three-dimensional culture containing human articular chondrocytes with induced terminal differentiation changes and preparation process and uses of the same |
06/25/2013 | US8470372 Material with immunogenicity |
06/25/2013 | US8470342 Methods of altering an immune response induced by CpG oligodeoxynucleotides |
06/25/2013 | US8470335 Recombinant SARS-CoV nsp12 and the use of thereof and the method for producing it |
06/25/2013 | US8470326 Monoclonal antibody therapy for pancreas cancer |
06/25/2013 | US8470317 B7RP-1 antagonists |
06/25/2013 | CA2703490C Regulatory elements associated with cbf transcription factor of rye |
06/25/2013 | CA2653566C Compounds and methods for immunotherapy and diagnosis of tuberculosis |
06/25/2013 | CA2648274C Unsaturated fatty acid synthase gene originating in marchantiales plant and utilization of the same |
06/25/2013 | CA2633074C Elongase genes and uses thereof |
06/25/2013 | CA2619139C Cell-based microarrays and methods of use |
06/25/2013 | CA2587923C Genetic variant of the annexin a5 gene |
06/25/2013 | CA2583147C Chimeric vectors |
06/25/2013 | CA2545255C Interleukin-10 antibodies |
06/25/2013 | CA2541294C Rna virus-derived plant expression system |
06/25/2013 | CA2524493C Corn event tc1507 and methods for detection thereof |
06/25/2013 | CA2522894C Pharmaceutical composition comprising a bispecific antibody specific for epcam |
06/25/2013 | CA2492097C Signal for packaging of influenza virus vectors |
06/25/2013 | CA2454578C Modified human thymic stromal lymphopoietin |
06/25/2013 | CA2446110C A system for inducible expression in eukaryotic cells |
06/25/2013 | CA2409714C Modification of bacteria |
06/25/2013 | CA2407460C Targeted modification of chromatin structure |
06/25/2013 | CA2402718C Fish vaccine against piscirickettsia salmonis |
06/25/2013 | CA2366211C Hyphal growth in fungi |
06/25/2013 | CA2347849C Omp85 proteins of neisseria gonorrhoeae and neisseria meningitidis, compositions containing same and methods of use thereof |
06/25/2013 | CA2313169C Engraftable neural progenitor and stem cells for brain tumor therapy |
06/25/2013 | CA2244403C Method of spotting probe on solid support, probe array and method of manufacturing thereof, and method of detecting target substance and method of identifying structure of target substance using probe array |
06/25/2013 | CA2214453C Novel avian cytokines and genetic sequences encoding same |
06/20/2013 | WO2013090861A1 Alpha-aminoamidine polymers and uses thereof |
06/20/2013 | WO2013090857A1 Identification of two novel biomarkers for niemann-pick disease type c |
06/20/2013 | WO2013090814A2 p-Coumaroyl-CoA:Monolignol Transferase |
06/20/2013 | WO2013090734A1 Method for improved transformation using agrobacterium |
06/20/2013 | WO2013090644A2 Anti-hiv antibodies having increased potency and breadth |
06/20/2013 | WO2013090620A1 Cancer diagnostics using non-coding transcripts |
06/20/2013 | WO2013090419A1 Gene expression signatures for detection of underlying philadelphia chromosome-like (ph-like) events and therapeutic targeting in leukemia |
06/20/2013 | WO2013089882A2 Recurrent gene fusions in breast cancer |
06/20/2013 | WO2013089819A2 Microrna mediated neuronal cell induction |
06/20/2013 | WO2013089738A1 Compositions and methods for exosome targeted expression |
06/20/2013 | WO2013089658A1 Method and device for performing micro-operations on a vesicular object |
06/20/2013 | WO2013089614A1 Usage of oligonucleotides in plant biology |
06/20/2013 | WO2013089522A1 Novel oligonucleotide conjugates and use thereof |
06/20/2013 | WO2013089496A1 Broad-spectrum neutralizing monoclonal antibody having high potential derived from h1n1-infected patients, and composition containing same for treating the virus |
06/20/2013 | WO2013089478A2 Method for preparing cysteine or a derivative thereof using a novel o-phosphoserine sulfhydrylase |
06/20/2013 | WO2013089283A1 Chimeric double-stranded nucleic acid |
06/20/2013 | WO2013089252A1 Modification of helper t cell-inducing polypeptide |
06/20/2013 | WO2013089166A1 Fimbriae type of porphyromonas gulae |
06/20/2013 | WO2013089157A1 Oligonucleotide and therapeutic agent for hyperlipidemia containing same as active ingredient |
06/20/2013 | WO2013089123A1 Gene targeting vector, and method for using same |
06/20/2013 | WO2013089063A1 Method for detecting methylated cytosine by using bisulfite reaction |
06/20/2013 | WO2013088935A1 Nucleic acid amplification method |
06/20/2013 | WO2013088920A1 Yeast having freezing stress resistance |
06/20/2013 | WO2013088853A1 Oligonucleotide, glucocorticoid sensitivity enhancer, drug composition, and expression vector |
06/20/2013 | WO2013088587A1 Recombinant protein capable of binding to troponin-i from human cardiac muscle specifically and rapidly |
06/20/2013 | WO2013088537A1 Cell culture container, and automated cell subculture device and cell subculture method using same |
06/20/2013 | WO2013088446A1 Compositions and methods for modifying a predetermined target nucleic acid sequence |
06/20/2013 | WO2013088438A1 Methods of modulating stomata conductance and plant expression constructs for executing same |
06/20/2013 | WO2013088338A1 Micrornas and uses therof |
06/20/2013 | WO2013088110A1 Annexin-a1 transgenic animals |
06/20/2013 | WO2013087968A1 Method for obtaining data that can be used for the diagnosis and prognosis of neurosensory hypoacusis |
06/20/2013 | WO2013087884A1 Mutant microorganisms to synthesize colanic acid, mannosylated and/or fucosylated oligosaccharides |
06/20/2013 | WO2013087833A1 Method for plant improvement |
06/20/2013 | WO2013087821A1 Overproduction of jasmonates in transgenic plants |
06/20/2013 | WO2013087215A1 General strategy for antibody library screening |
06/20/2013 | WO2013087043A1 Flavobacterium strain, endo-alginate lyase encoding gene, and preparation and use of said gene |
06/20/2013 | WO2013087033A1 CELL MODEL BASED ON STAT3 AND NF-ĸB DUAL-SIGNALLING PATHWAY AS TARGET FOR SCREENING ANTI-TUMOUR DRUG AND CONSTRUCTION AND USE THEREOF |
06/20/2013 | WO2013087029A1 Polypeptides having endoglucanase activity and polynucleotides encoding same |
06/20/2013 | WO2013087027A1 Polypeptides having laccase activity and polynucleotides encoding same |
06/20/2013 | WO2013086907A1 Genetic engineering strain for producing succinic acid by using glucose and method for producing acid by fermenting the strain |
06/20/2013 | WO2013086809A1 Application of saa1β/β homozygote in liver cirrhosis prognosis diagnosis and liver cirrhosis diagnosis |
06/20/2013 | WO2013086639A1 Mutations indicative of weaver syndrome |
06/20/2013 | WO2013086636A1 Soluble igf receptor fc fusion proteins and uses thereof |
06/20/2013 | WO2013086633A1 Fungal cells and fermentation processes |
06/20/2013 | WO2013086583A1 Assay and method for identifying compounds that inhibit excitotoxic signals |
06/20/2013 | WO2013067451A3 Methods and compositions for diagnosing, prognosing, and treating neurological conditions |
06/20/2013 | WO2013063528A3 Isoprene synthase variants with improved solubility for production of isoprene |
06/20/2013 | WO2013063315A3 Methods and compositions for modification of the hprt locus |
06/20/2013 | WO2013062365A3 Mutant ctla4 gene transfected t cell and composition including same for anticancer immunotherapy |
06/20/2013 | WO2013062327A3 Atpg4 protein having productivity increase function, anti-aging function, stress resistance function of plants, genes thereof, and uses thereof |
06/20/2013 | WO2013062258A3 Tuber-tissue-specific laccase promoter derived from potato, and use therefor |
06/20/2013 | WO2013061098A3 Functional isotype switching of chimaeric antibody chains & chimaeric animals expressing different igh isotypes |
06/20/2013 | WO2013058654A3 Methods for producing cinnamolide and/or drimendiol |
06/20/2013 | WO2013055418A3 Cross-protective arenavirus vaccines and their method of use |
06/20/2013 | WO2013053008A3 Molecules which bind clec9a |
06/20/2013 | WO2013052908A3 Nucleic acid molecules that target rps6 and confer resistance to coleopteran pests |